Wells Fargo’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.9M | Sell |
68,488
-32,055
| -32% | -$5.6M | ﹤0.01% | 1830 |
|
|
2025
Q4 | $17.1M | Buy |
100,543
+13,724
| +16% | +$2.1M | ﹤0.01% | 1608 |
|
|
2025
Q3 | $11.4M | Buy |
86,819
+6,838
| +9% | +$820K | ﹤0.01% | 1891 |
|
|
2025
Q2 | $8.49M | Sell |
79,981
-19,148
| -19% | -$2.08M | ﹤0.01% | 2042 |
|
|
2025
Q1 | $12.3M | Buy |
99,129
+2,177
| +2% | +$284K | ﹤0.01% | 1700 |
|
|
2024
Q4 | $11.9M | Sell |
96,952
-20,063
| -17% | -$2.36M | ﹤0.01% | 1723 |
|
|
2024
Q3 | $13M | Sell |
117,015
-87,111
| -43% | -$9.55M | ﹤0.01% | 1610 |
|
|
2024
Q2 | $21.8M | Sell |
204,126
-18,232
| -8% | -$2M | 0.01% | 1194 |
|
|
2024
Q1 | $26.8M | Buy |
222,358
+111,301
| +100% | +$13.6M | 0.01% | 1053 |
|
|
2023
Q4 | $13.7M | Sell |
111,057
-8,016
| -7% | -$1M | ﹤0.01% | 1439 |
|
|
2023
Q3 | $15.4M | Buy |
119,073
+16,813
| +16% | +$2.24M | ﹤0.01% | 1265 |
|
|
2023
Q2 | $12.7M | Sell |
102,260
-467
| -0.5% | -$62.8K | ﹤0.01% | 1418 |
|
|
2023
Q1 | $15M | Sell |
102,727
-1,924
| -2% | -$285K | ﹤0.01% | 1299 |
|
|
2022
Q4 | $16.7M | Sell |
104,651
-13,766
| -12% | -$2.02M | 0.01% | 1216 |
|
|
2022
Q3 | $15.8M | Buy |
118,417
+11,412
| +11% | +$1.74M | 0.01% | 1221 |
|
|
2022
Q2 | $16.7M | Buy |
107,005
+3,707
| +4% | +$571K | 0.01% | 1242 |
|
|
2022
Q1 | $16.1M | Buy |
103,298
+33,770
| +49% | +$4.9M | ﹤0.01% | 1463 |
|
|
2021
Q4 | $8.86M | Sell |
69,528
-43,770
| -39% | -$5.75M | ﹤0.01% | 1971 |
|
|
2021
Q3 | $14.8M | Buy |
113,298
+27,250
| +32% | +$4.12M | ﹤0.01% | 1893 |
|
|
2021
Q2 | $15.3M | Sell |
86,048
-21,668
| -20% | -$3.75M | ﹤0.01% | 1881 |
|
|
2021
Q1 | $17.7M | Sell |
107,716
-10,760
| -9% | -$1.77M | ﹤0.01% | 1764 |
|
|
2020
Q4 | $19.6M | Sell |
118,476
-2,288
| -2% | -$341K | ﹤0.01% | 1575 |
|
|
2020
Q3 | $17.2M | Sell |
120,764
-188,050
| -61% | -$23.3M | ﹤0.01% | 1519 |
|
|
2020
Q2 | $34.1M | Sell |
308,814
-40,115
| -11% | -$4.44M | 0.01% | 1053 |
|
|
2020
Q1 | $34.8M | Sell |
348,929
-12,413
| -3% | -$1.6M | 0.01% | 942 |
|
|
2019
Q4 | $53.9M | Sell |
361,342
-7,361
| -2% | -$1M | 0.01% | 881 |
|
|
2019
Q3 | $47.2M | Sell |
368,703
-17,913
| -5% | -$2.4M | 0.01% | 944 |
|
|
2019
Q2 | $55.1M | Sell |
386,616
-48,032
| -11% | -$6.45M | 0.02% | 867 |
|
|
2019
Q1 | $62.1M | Sell |
434,648
-46,235
| -10% | -$6.03M | 0.02% | 772 |
|
|
2018
Q4 | $59.6M | Sell |
480,883
-24,212
| -5% | -$3.59M | 0.02% | 735 |
|
|
2018
Q3 | $84.9M | Sell |
505,095
-5,055
| -1% | -$869K | 0.02% | 660 |
|
|
2018
Q2 | $87.9M | Buy |
510,150
+48,455
| +10% | +$7.92M | 0.03% | 623 |
|
|
2018
Q1 | $69.7M | Sell |
461,695
-21,671
| -4% | -$3.18M | 0.02% | 741 |
|
|
2017
Q4 | $65.1M | Sell |
483,366
-12,283
| -2% | -$1.7M | 0.02% | 758 |
|
|
2017
Q3 | $72.5M | Sell |
495,649
-1,781
| -0.4% | -$269K | 0.02% | 689 |
|
|
2017
Q2 | $77.4M | Sell |
497,430
-6,329
| -1% | -$968K | 0.02% | 658 |
|
|
2017
Q1 | $73.1M | Buy |
503,759
+2,529
| +0.5% | +$329K | 0.02% | 669 |
|
|
2016
Q4 | $54.6M | Sell |
501,230
-4,849
| -1% | -$540K | 0.02% | 790 |
|
|
2016
Q3 | $61.5M | Buy |
506,079
+74,342
| +17% | +$10M | 0.02% | 691 |
|
|
2016
Q2 | $61M | Buy |
431,737
+21,370
| +5% | +$3.15M | 0.02% | 659 |
|
|
2016
Q1 | $53.6M | Buy |
410,367
+71,560
| +21% | +$8.91M | 0.02% | 718 |
|
|
2015
Q4 | $47.6M | Buy |
338,807
+12,962
| +4% | +$1.8M | 0.02% | 790 |
|
|
2015
Q3 | $43.3M | Sell |
325,845
-222,882
| -41% | -$38.4M | 0.02% | 823 |
|
|
2015
Q2 | $96.6M | Sell |
548,727
-379,250
| -41% | -$68.1M | 0.04% | 508 |
|
|
2015
Q1 | $160M | Sell |
927,977
-116,536
| -11% | -$20M | 0.06% | 343 |
|
|
2014
Q4 | $171M | Sell |
1,044,513
-717,507
| -41% | -$119M | 0.07% | 322 |
|
|
2014
Q3 | $283M | Sell |
1,762,020
-329,975
| -16% | -$50.7M | 0.12% | 212 |
|
|
2014
Q2 | $308M | Buy |
2,091,995
+63,605
| +3% | +$8.82M | 0.13% | 203 |
|
|
2014
Q1 | $281M | Buy |
2,028,390
+1,676,455
| +476% | +$252M | 0.12% | 212 |
|
|
2013
Q4 | $44.5M | Sell |
351,935
-199,583
| -36% | -$20.7M | 0.02% | 804 |
|
|
2013
Q3 | $50.7M | Buy |
551,518
+31,176
| +6% | +$2.51M | 0.02% | 676 |
|
|
2013
Q2 | $35.8M | Buy |
+520,342
| New | +$31.8M | 0.02% | 808 |
|
Other funds holding JAZZ
VPM
VCM
EC
Wells Fargo's JAZZ Position: Q1 2026 in Review
Wells Fargo reduced its Jazz Pharmaceuticals (JAZZ) stake by 32% in Q1 2026, selling an estimated $5.6M and leaving 68,488 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1830.
Wells Fargo first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $308M in Q2 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Wells Fargo held 68,488 shares of Jazz Pharmaceuticals worth $12.9M as of Q1 2026.
- Wells Fargo sold 32,055 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.6M.
- Jazz Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1830 holding.
- Wells Fargo first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Jazz Pharmaceuticals position peaked at $308M in Q2 2014.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.